Filing Details
- Accession Number:
- 0001628280-24-048437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 16:17:06
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-19 16:17:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1723128 | Amneal Pharmaceuticals Inc. | AMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1906486 | B. Jason Daly | C/O Amneal Pharmaceuticals, Inc. 400 Crossing Boulevard Bridgewater NJ 08807 | Svp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-11-15 | 43,657 | $8.61 | 13,665 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $9.00 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
